Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma

被引:14
作者
Ye, Peng [1 ]
Qu, Chang-Fa [2 ]
Hu, Xue-Lin [3 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Thorac Surg, Hangzhou 310003, Zhejiang, Peoples R China
[2] Harbin Med Univ, Canc Hosp, Dept Thorac Surg, 150 Nangang Area, Harbin 150080, Peoples R China
[3] 1 Peoples Hosp Zhangjiagang, Dept Thorac Surg, Zhangjiagang 215600, Peoples R China
关键词
Esophageal carcinoma; IGF-1; IGF-IR; IGFBP-3; Methylation; Clinicopathological features; Prognosis; BINDING PROTEIN-3 IGFBP-3; DNA METHYLATION; GROWTH; EXPRESSION; CANCER; TUMOR; GENES;
D O I
10.1007/s13277-015-4489-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study is to investigate IGF-1, IGF-1R, and IGFBP-3 methylations in esophageal carcinoma (EC) patients and their relationship with the development and prognosis of EC. This study population consisted of 264 patients (case group) whom EC radical resection was performed and 283 healthy individuals (control group). Methylation-specific PCR (MSP) detected the methylation status of IGF-1, IGF-1R, and IGFBP-3 in the peripheral blood in both groups. The expressions of IGF-1, IGF-1R, and IGFBP-3 in EC and adjacent normal tissues were detected by immunohistochemistry (IHC). The methylation rates of IGF-1, IGF-1R, IGFBP3, and IGF-1+IGF1R+IGFBP3 in the case group were higher than those in the control group (all P<0.05). Additionally, there were statistical significances for the methylation rates of IGF-1, IGF-1R, IGFBP3, and IGF-1+IGF1R+IGFBP3 IGF-1 among patients of different clinicopathological features (all P<0.05). The positive expression rates of IGF-1 and IGF-1R in EC were significantly higher than those in adjacent normal tissues (both P<0.001), and the rate of IGFBP-3 in EC was significantly lower than that in adjacent normal tissues (P<0.05). Correlation analysis showed that IGF-1 and IGF1R gene promoter methylation was positively correlated with the positive expressions of IGF-1 (r=0.139, P=0.024) and IGF-1R (r=0.135, P=0.028), while the IGFBP3 methylation was negatively correlated with the positive expression of IGFBP3 (r=-0.133, P=0.031). The positive expressions of IGF-1, IGF-1R, and IGFBP-3 were related to different clinicopathological features (all P<0.05). Cox multivariate analysis results showed that methylation status of IGF-1, IGF-1R, and IGF-1+IGF1R+IGFBP3 ; expressions of IGF-1 and IGF-1R protein; infiltration depth; and lymph node metastasis (LNM) were independent factors of EC prognosis. Our study demonstrated that methylation of IGF-1, IGF1R, IGFBP3, and IGF-1+IGF1R+IGFBP3 was closely linked with the occurrence of EC and patients' clinicopathological features. Besides, the methylation status of the target genes and the expressions of IGF-1 and IGF-1R protein were independent factors of EC prognosis, which could provide a direction for the prognosis and treatment of EC.
引用
收藏
页码:6893 / 6904
页数:12
相关论文
共 50 条
[41]   Expression of IGF-1 and IGF-1R and Their Relation to Clinicopathological Factors in Colorectal Cancer [J].
Shiratsuchi, Ichitarou ;
Akagi, Yoshito ;
Kawahara, Akihiko ;
Kinugasa, Tetsushi ;
Romeo, Kansakar ;
Yoshida, Takefumi ;
Ryu, Yasuhiko ;
Gotanda, Yukito ;
Kage, Masayoshi ;
Shirouzu, Kazuo .
ANTICANCER RESEARCH, 2011, 31 (07) :2541-2545
[42]   IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai [J].
N M Probst-Hensch ;
J-M Yuan ;
F Z Stanczyk ;
Y-T Gao ;
R K Ross ;
M C Yu .
British Journal of Cancer, 2001, 85 :1695-1699
[43]   IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai [J].
Probst-Hensch, NM ;
Yuan, JM ;
Stanczyk, FZ ;
Gao, YT ;
Ross, RK ;
Yu, MC .
BRITISH JOURNAL OF CANCER, 2001, 85 (11) :1695-1699
[44]   IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer [J].
Gerrit Peters ;
Silvia Gongoll ;
Cord Langner ;
Michael Mengel ;
Pompiliu Piso ;
Jürgen Klempnauer ;
Josef Rüschoff ;
Hans Kreipe ;
Reinhard von Wasielewski .
Virchows Archiv, 2003, 443 :139-145
[45]   Oral Administration of Microencapsulated B. Longum BAA-999 and Lycopene Modulates IGF-1/IGF-1R/IGFBP3 Protein Expressions in a Colorectal Murine Model [J].
Valadez-Bustos, Nancy ;
Escamilla-Silva, Eleazar M. ;
Garcia-Vazquez, Francisco J. ;
Gallegos-Corona, Marco A. ;
Amaya-Llano, Silvia L. ;
Ramos-Gomez, Minerva .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (17)
[46]   IGF-1 and IGFBP-3 polymorphisms predict risk for non-traumatic osteonecrosis of the femoral head [J].
Wei, Wei ;
Wei, Biao-Fang ;
Liu, Xin ;
He, Wei .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (11) :11928-11935
[47]   Are plasma insulin-like growth factor 1 (IGF-1) and IGF-binding protein 3 (IGFBP-3) useful markers of prostate cancer? [J].
Lopez, JB ;
Sahabudin, RM ;
Chin, LP .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2004, 19 (02) :164-167
[48]   Down-regulation of IGF-1/IGF-1R in hippocampus of rats with vascular dementia [J].
Gong, Xiuqun ;
Ma, Minmin ;
Fan, Xinying ;
Li, Mingquan ;
Liu, Qian ;
Liu, Xinfeng ;
Xu, Gelin .
NEUROSCIENCE LETTERS, 2012, 513 (01) :20-24
[49]   Improving expression of recombinant human IGF-1 using IGF-1R knockout CHO cell lines [J].
Romand, Sandrine ;
Jostock, Thomas ;
Fornaro, Mara ;
Schmidt, Joerg ;
Ritter, Anett ;
Wilms, Burkhard ;
Laux, Holger .
BIOTECHNOLOGY AND BIOENGINEERING, 2016, 113 (05) :1094-1101
[50]   Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets [J].
Zhang, Yinqi ;
Gao, Chengqi ;
Cao, Fei ;
Wu, Ying ;
Chen, Shuanggang ;
Han, Xue ;
Mo, Jingqin ;
Qiu, Zhiyu ;
Fan, Weijun ;
Zhou, Penghui ;
Shen, Lujun .
FRONTIERS IN ONCOLOGY, 2021, 11